Compare Fox Corp Class A (FOXA) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Fox Corp Class A trades at $62.63 (market cap $24.79B), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Fox Corp Class A pays the higher dividend (0.93%). Which is the better fit depends on your goals.
| FOXA | GEHC | |
|---|---|---|
Market Cap | $24.79B | $30.93B |
Volume | 2,972,036 | 5,033,451 |
Sector | Media | Health |
52-Week High | $76.11 | $88.16 |
52-Week Low | $48.79 | $59.48 |
Typical Hold Time | 35 Days | — |
Enterprise Value | $28.16B | $39.39B |
Dividend Yield | 0.93% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOXA trades at $62.50, down slightly by 0.14% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.79 surpassing the $1.44 estimate. Revenue grew to $16.30 billion in 2025, and net income reached $2.26 billion. Analysts maintain a bullish consensus with a $72.00 price target, though the pending $22 billion Roku acquisition faces extended DOJ scrutiny, a key near-term focus.
The outlook for FOXA is cautiously optimistic, supported by solid fundamentals and analyst confidence, but weighed by regulatory risks from the Roku deal and a projected earnings dip in 2026. Investment appeal lies in valuation metrics like a P/E of 16.2 and robust cash flow, though investors must monitor deal approval progress and competitive pressures in media.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
